PER 2.50% 8.2¢ percheron therapeutics limited

Ann: Trading Halt, page-136

  1. 798 Posts.
    lightbulb Created with Sketch. 301
    this reminds me of DXB. Unfortunately cash strapped before pivotal trial and a raise was necessary. People selling or claiming to will end up selling at yearly lows because of why? “Don’t trust management”, “no faith”. Story hasn’t changed, what were we going to do? how many examples are on the asx of partnerships during P2. Not many. Lot of companies in P3 and no partnerships. It’s the nature of the beast (industry and asx) right now

    DXB up almost 50% since drop from CR, I’m taking this as an opportunity to increase through the SPP in coming weeks or if it drops below that so be it I’ll buy more.

    I see our current phase as a caterpillar just coming out of its chrysalis.

    my rationalization is why take the loss if you’ve lasted to the last capital raise before a binary outcome clinical trial result? Sure I maybe be a masochist for holding ANP but that’s too far for me.

    still want to know if AF works at Anp still though lol
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.0¢ 8.2¢ 8.0¢ $216.5K 2.688M

Buyers (Bids)

No. Vol. Price($)
5 317461 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 285087 1
View Market Depth
Last trade - 16.10pm 26/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.